Chronic myeloid leukemia (CML) is a well-characterized oncological disease in which virtually all patients possess a translocation (9;22) that generates the tyrosine kinase BCR::ABL1 protein. This evidence concerns the gene BCR and chronic myelogenous leukemia, BCR-ABL1 positive.